Tag Archive for ‘ACS Cancer Research Program’
Optimizing treatment of colorectal liver metastases through the use of clinical trial data
Describes the results of clinical trials using ctDNA to improve survival for patients at high risk of cancer recurrence.
Synoptic reporting for cancer surgery: Current requirements and future state
Describes the benefits of synoptic reporting, specifically its ability to automate data capture, promote interoperability, and increase research opportunities.
Tailoring systemic therapy for HER2+ early breast cancer—The CompassHER2 Trials
Summarizes the shared scientific mission of the CompassHER2 Trials, which is to optimize systemic therapy for patients with clinical stage II–III HER2+ early-stage breast cancer.
Improving patient-centered breast cancer treatment decisions
Describes the development and goals of the SharEs study, which aims to enhance patient-centered communication for breast cancer patients.
Role of radiation in the treatment of pancreatic adenocarcinoma in the neoadjuvant setting
Summarizes the findings of recent studies examining the role of radiation therapy in the treatment of pancreatic ductal adenocarcinoma in the contemporary neoadjuvant setting.
Tips and strategies to maximize the use and impact of social media
The benefits of social media use for the oncology community are summarized.
Surgical oncology for the general surgeon
The latest advances in tumor biology as they pertain to the surgical care of cancer patients are summarized.
Surgical emergencies in advanced cancer patients: How to navigate a perilous time
Seeking input from a patient’s oncologist is key when managing common clinical scenarios in advanced cancer patients.
Clinical trial for patients with incidentally discovered T2 or T3 gallbladder cancer: OPT-IN/EA2197
Describes the aim and structure of the OPT-IN trial, which was developed to address the high recurrence rates seen in patients with presumably localized disease after re-resection of incidentally diagnosed gallbladder cancer.
Neoadjuvant immunotherapy: Results in melanoma show promise and pave the way for other solid tumors
It is astonishing to consider that it was only 10 years ago that the first immune checkpoint blockade inhibitor garnered Food and Drug Administration approval. Modern immunotherapy began as single-agent therapy in patients with widely metastatic disease in just a few types of cancer, whereas today, hundreds of different agents targeting various aspects of the […]
Trials explore whether endocrine therapy can delay or avert surgery in low-risk DCIS
Over the last several decades, the widespread implementation and uptake of screening mammography has contributed to earlier diagnosis of breast cancer and improvements in breast cancer mortality. However, the screening has led to a significant rise in the detection of ductal carcinoma in situ (DCIS), which is a pre-cancer of the breast. Much like invasive […]
